126 related articles for article (PubMed ID: 4506026)
1. Clinical and morphological side-effects of busulfan (Myleran) treatment.
Dahlgren S; Holm G; Svanborg N; Watz R
Acta Med Scand; 1972; 192(1-2):129-35. PubMed ID: 4506026
[No Abstract] [Full Text] [Related]
2. [Toxic effects of busulfan (myleran) in the treatment of chronic myeolid leukemia].
Japp H
Schweiz Med Wochenschr; 1974 Aug; 104(32):1115-9. PubMed ID: 4548568
[No Abstract] [Full Text] [Related]
3. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1971.
Castleman B; McNeely BU
N Engl J Med; 1971 Oct; 285(15):847-55. PubMed ID: 5315205
[No Abstract] [Full Text] [Related]
4. [Pulmonary fibrosis after busulfan therapy].
Jandl H; Franke A; Albrecht G
Z Gesamte Inn Med; 1975 Dec; 30(24):799-801. PubMed ID: 1062873
[TBL] [Abstract][Full Text] [Related]
5. [Undesired side-effects of busulfan].
Japp H
Dtsch Med Wochenschr; 1974 Dec; 99(51):2614-5. PubMed ID: 4530768
[No Abstract] [Full Text] [Related]
6. [Pulmonary alveolar fibrosis caused by Myleran (busulfan)].
Etcheberry R; Becker P; Delmastro J; Donoso S
Rev Med Chil; 1973 Jan; 101(1):42-6. PubMed ID: 4518637
[No Abstract] [Full Text] [Related]
7. [Busulfan lung. Pulmonary fibrosis caused by Myleran].
Koch H; Lesch R
Med Welt; 1976 Feb; 27(7):308-11. PubMed ID: 1062649
[No Abstract] [Full Text] [Related]
8. Toxic manifestations of busulfan therapy.
Burns WA; McFarland W; Matthews MJ
Med Ann Dist Columbia; 1971 Sep; 40(9):567-72. PubMed ID: 5315525
[No Abstract] [Full Text] [Related]
9. Busulfan lung.
Pearl M
Am J Dis Child; 1977 Jun; 131(6):650-2. PubMed ID: 266839
[TBL] [Abstract][Full Text] [Related]
10. [Clinical heterogeneity of Myleran-induced pneumopathy. Apropos of 2 further cases and review of the literature].
Gyger M; LeGresley LP; Boulianne P; Lacombe M; Lavallée R; Bonny Y; Boileau J; D'Angelo G
Union Med Can; 1977 Nov; 106(11):1522-8. PubMed ID: 270864
[No Abstract] [Full Text] [Related]
11. [Myleran lung in chronic myelosis].
Pietschmann H; Kolarz G
Wien Z Inn Med; 1973; 54(4):150-5. PubMed ID: 4519579
[No Abstract] [Full Text] [Related]
12. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M
Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954
[No Abstract] [Full Text] [Related]
13. Busulfan lung. Report of two cases and review of the literature.
Podoll LN; Winkler SS
Am J Roentgenol Radium Ther Nucl Med; 1974 Jan; 120(1):151-6. PubMed ID: 4520939
[No Abstract] [Full Text] [Related]
14. Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia.
Kirschner RH; Esterly JR
Cancer; 1971 May; 27(5):1074-80. PubMed ID: 5281244
[No Abstract] [Full Text] [Related]
15. Busulfan-induced pulmonary disease. Report of a case and review of the literature.
Burns WA; McFarland W; Matthews MJ
Am Rev Respir Dis; 1970 Mar; 101(3):408-13. PubMed ID: 5263678
[No Abstract] [Full Text] [Related]
16. Diagnosis of busulfan lung by transcatheter biopsy.
Brynes RK; Mostafavipour SH; Fennessy JJ; Variakojis D
Chest; 1973 Dec; 64(6):771-3. PubMed ID: 4519106
[No Abstract] [Full Text] [Related]
17. [Fatal pulmonary fibrosis, with cellular lesions of the lung and pancreas, attributed to busulfan].
Batzenschlager A; Oberling F; Guerbaoui M; Vetter JM
Arch Anat Pathol (Paris); 1972 Sep; 20(3):291-4. PubMed ID: 4507846
[No Abstract] [Full Text] [Related]
18. Endocardial fibrosis following busulfan treatment.
Weinberger A; Pinkhas J; Sandbank U; Shaklai M; de Vries A
JAMA; 1975 Feb; 231(5):495. PubMed ID: 1054099
[No Abstract] [Full Text] [Related]
19. The effect of busulfan on human epithelia.
Koss LG; Melamed MR; Mayer K
Am J Clin Pathol; 1965 Oct; 44(4):385-97. PubMed ID: 5214802
[No Abstract] [Full Text] [Related]
20. [Cutaneous pigmentations during myeloid leukemia treated with myleran].
Marchal G; Bilski-Pasquier G; Maunand
Sem Ther; 1963 Nov; 39(9):565-8. PubMed ID: 5230097
[No Abstract] [Full Text] [Related]
[Next] [New Search]
